Self-association of human PCSK9 correlates with its LDLR-degrading activity

Biochemistry
Daping FanSergio Fazio

Abstract

Genetic studies have demonstrated an important role for proprotein convertase subtilisin/kexin type 9 (PCSK9) as a determinant of plasma cholesterol levels. However, the underlying molecular mechanism is not completely understood. To this end, we have generated a mammalian cell expression system for human PCSK9 and its mutants and produced transgenic mice expressing human PCSK9. HEK293T cells transfected with the human PCSK9 DNA construct expressed and secreted PCSK9 and displayed decreased LDLR levels; functional PCSK9 protein was purified from the conditioned medium. In vitro studies showed that PCSK9 self-associated in a concentration-, temperature-, and pH-dependent manner. A mixture of PCSK9 monomers, dimers, and trimers displayed an enhanced LDLR degrading activity compared to monomeric PCSK9. A gain-of-function mutant, D374Y, displayed greatly increased self-association compared to wild-type PCSK9. Moreover, we demonstrated that the catalytic domain of PCSK9 is responsible for the self-association. Self-association of PCSK9 was enhanced by incubation with mouse apoE-/- VLDL and inhibited by incubation with both human and mouse HDL. When PCSK9 protein was incubated with total serum, it partially associated with LDL and HD...Continue Reading

References

Jul 17, 1998·Current Opinion in Chemical Biology·D F Steiner
Jul 20, 1999·The Journal of Biological Chemistry·A ZhouD F Steiner
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nabil G SeidahMichel Chretien
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Nov 19, 2003·Archives of Biochemistry and Biophysics·Saule NaureckieneBrendan Bingham
Jan 17, 2004·Human Genetics·Kirsten M TimmsDonna M Shattuck
Mar 16, 2005·Current Opinion in Lipidology·Kara N Maxwell, Jan L Breslow
Apr 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shirya RashidJay D Horton
Oct 15, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Rossi P NaoumovaAnne K Soutar
Nov 30, 2005·Archives of Medical Research·Ludivina Robles-OsorioCarlos A Aguilar-Salinas
Jan 21, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Knut Erik BergeTrond P Leren
Feb 8, 2006·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Petar N GrozdanovMariana D Dabeva
Feb 9, 2006·American Journal of Human Genetics·Ingrid K KotowskiHelen H Hobbs
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Mar 31, 2006·Human Molecular Genetics·Jamie CameronTrond P Leren
Aug 9, 2006·Journal of Neurochemistry·Steve PoirierNabil G Seidah
Nov 3, 2006·The Journal of Clinical Investigation·Thomas A LagaceJay D Horton
Dec 5, 2006·Journal of Medical Genetics·S E HumphriesUNKNOWN Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee
Mar 8, 2007·The Journal of Biological Chemistry·Daping FanSergio Fazio
Apr 17, 2007·Nature Structural & Molecular Biology·David CunninghamXiayang Qiu
May 12, 2007·The Journal of Biological Chemistry·Timothy S FisherAyesha Sitlani
May 16, 2007·Structure·Derek E PiperNigel P C Walker
Jun 1, 2007·The Journal of Biological Chemistry·Markey C McNuttJay D Horton
Jul 5, 2007·The Biochemical Journal·Jun LiJennifer L Harris

❮ Previous
Next ❯

Citations

Feb 23, 2012·International Journal of Biological Sciences·Liwen ZhangAyesha Sitlani
Oct 29, 2013·Annual Review of Pharmacology and Toxicology·Giuseppe Danilo NorataAlberico Luigi Catapano
Oct 13, 2010·The Journal of Biological Chemistry·Suzanne BenjannetNabil G Seidah
Sep 4, 2015·The Journal of Pathology·Ilaria GiunzioniSergio Fazio
Jul 16, 2010·Current Opinion in Cell Biology·Frederick R Maxfield, Gerrit van Meer
Jul 8, 2010·Bioorganic & Medicinal Chemistry Letters·Amit BasakAjoy Basak
Aug 25, 2015·Journal of the American Chemical Society·Andrew M WatkinsParamjit S Arora
Aug 2, 2008·Trends in Biochemical Sciences·Philippe CostetBertrand Cariou
Nov 10, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Nicola FerriMassimiliano Ruscica
Mar 17, 2015·Trends in Cardiovascular Medicine·Nihar R Desai, Marc S Sabatine
Apr 21, 2016·Journal of Thrombosis and Thrombolysis·James LatimerVijay Kunadian
Jan 21, 2015·Basic Research in Cardiology·Rainer SchulzUlrich Laufs
May 21, 2011·Atherosclerosis·Bertrand CariouPhilippe Costet
Jul 25, 2008·Atherosclerosis·Gilles LambertDerek E Piper
Feb 19, 2015·Current Opinion in Endocrinology, Diabetes, and Obesity·Hagai TavoriSergio Fazio
Aug 9, 2016·Cardiovascular Research·Giuseppe Danilo NorataAlberico L Catapano
Sep 23, 2014·Expert Review of Cardiovascular Therapy·Hagai TavoriShirya Rashid
Mar 18, 2017·Journal of Atherosclerosis and Thrombosis·Michael D Shapiro, Sergio Fazio
Dec 7, 2017·The EPMA Journal·Michał WicińskiGrzegorz Grześk
Jul 19, 2018·Bioinformatics·Ruben Sanchez-GarciaJoan Segura
Jul 22, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Alan DaughertyUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular
Jul 22, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Kelsey E JarrettWilliam R Lagor
Jun 25, 2016·Circulation Research·Peter P Toth
Apr 29, 2016·Circulation Research·Hagai TavoriSergio Fazio
Jul 22, 2017·Circulation Research·Alan DaughertyUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular
Nov 23, 2018·Journal of Lipid Research·Adri M Galvan, John S Chorba
Feb 1, 2019·Circulation Research·Robert S RosensonWolfgang Koenig
Dec 10, 2008·Genetika·M Iu Mandel'shtam, V B Vasil'ev

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.